Abstract
5,8,11-Eicosatrienoic acid (20∶3ω9), a fatty acid increased in the platelet phospholipids of man and animals fed saturated fats, was either added to human platelets simultaneously with the aggregating agents, or incorporated into the platelet phospholipids by preincubation. 20∶3ω9 markedly increased the response of platelets to all aggregating agents tested when added simultaneously with the agent, but solely to thrombin and ionophore, after incorporation into the platelet phospholipids. The potentiating effects of 20∶3ω9 on thrombin aggregation do not appear to be related to prostaglandin formation, but rather to the production of a monohydroxy derivative through the lipoxygenase pathway.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Samuelsson, B. (1977) in Prostaglandins in Hematology, pp. 1–10, Spectrum Publication, New York.
Smith, J.B., Ingerman, C.M., and Silver, M.J. (1977) in Prostaglandins in Hematology, pp. 277–292, Spectrum Publication, New York.
Willis, A.L., Comai, K., Kuhn, D.C., and Paulsrud, J. (1974) Prostaglandins 8, 509–519.
Needleman, P., Raz, A., Minkes, M.S., Ferrendelli, J.A., and Sprecher, H. (1979) Proc. Natl. Acad. Sci. USA 76, 944–948.
Kingsbury, K.J., Brett, C., Stovold, R., Chapman, A., Anderson, J., and Morgan, D.M. (1974) Postgrad. Med. J. 50, 425–440.
Holman, R.T. (1960) J. Nutr. 70, 405–410.
McGregor, L., and Renaud, S. (1978) Thrombos. Res. 12, 921–927.
McGregor, L., Morazain, R., and Renaud, S. (1980) Lab. Invest. 43, 438–442.
Renaud, S., Dumont, E., Godsey, F., Morazain, R., and McGregor, L. (1981) in Nutrition in the 1980's, pp. 361–381, Alan R. Liss, New York.
Sprecher, H. (1971) Lipids 6, 889–894.
Lagarde, M., Bryon, P.A., Guichardant, M., and Dechavanne, M. (1980) Thrombos. Res. 17, 581–588.
Lagarde, M., Burtin, M., Dechavanne, M., Sicard, B., and Coiffier, B. (1980) Prostaglandins Med. 4, 177–183.
Lagarde, M., Guichardant, M., Menashi, S., and Crawford, N. (1982) J. Biol. Chem. 25, 3100–3104.
Mustard, J.F., Hegardt, B., Rowell, H.C., and McMillan, R.L. (1964) J. Lab. Clin. Med. 64, 548–559.
Wilhelm, T.E., Sankarappa, S.K., Van Rollins, M., and Sprecher, H. (1981) Prostaglandins 21, 323–332.
Lagarde, M., Gharib, A., and Dechavanne M. (1977) Clin. Chim. Acta 79, 255–259.
Bills, T.K., Smith, J.B., and Silver, M.J. (1977) in Prostaglandins in Hematology, pp. 27–55, Spectrum Publication, New York.
Knapp, H.R., Oelz, O., Roberts, J.L., Sweetman, B.J., Oates, J.A., and Reed, P.W. (1977) Proc. Natl. Acad. Sci. USA 74, 4251–4255.
Raz, A., Minkes, M., and Needleman, P. (1977) Biochim. Biophys. Acta 488, 305–311.
Dutilh, C.E., Haddeman, E., Jouvenaz, G.H., TenHoor, F., and Nugteren, D.H. (1979) Lipids 14, 241–246.
Dutilh, C.E., Haddeman, E., Don, J.A., and TenHoor, F. (1981) Prostaglandins Med. 6, 111–126.
Willis, A.L., Stone, K.J., Hart, M., Gibson, V., Marples, P., Botfield, E., Comai, K., and Kuhn, D.C. (1977) in Prostaglandins in Hematology pp. 371–310, Spectrum Publication, New York.
Author information
Authors and Affiliations
About this article
Cite this article
Lagarde, M., Burtin, M., Sprecher, H. et al. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation. Lipids 18, 291–294 (1983). https://doi.org/10.1007/BF02534704
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02534704